Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Abstract Although hepatocellular carcinoma (HCC) is one of the deadliest health burdens worldwide, few drugs are available for its clinical treatment. However, in recent years, major breakthroughs have been made in the development of new drugs due to intensive fundamental research and numerous clini...
Main Authors: | Xiang-Yuan Luo, Kong-Ming Wu, Xing-Xing He |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-021-01968-w |
Similar Items
-
Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
by: Ziyu Liu, et al.
Published: (2019-11-01) -
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
by: Claire Faltermeier, et al.
Published: (2015-09-01) -
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
by: Tella SH, et al.
Published: (2019-11-01) -
Advanced hepatocellular carcinoma. Review of targeted molecular drugs
by: Camargo Pinheiro Alves Rogério, et al.
Published: (2011-01-01) -
Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells
by: Robert D. Hoffman, et al.
Published: (2020-04-01)